Normative data for functional assessment of cancer therapy - General scale and its use for the interpretation of quality of life scores in cancer survivors

被引:95
作者
Holzner, B
Kemmler, G
Cella, D
De Paoli, C
Meraner, V
Kopp, M
Greil, R
Fleischhacker, WW
Sperner-Unterweger, B
机构
[1] Univ Innsbruck Hosp, Dept Biol Psychiat, A-6020 Innsbruck, Austria
[2] Univ Innsbruck Hosp, Dept Psychiat, A-6020 Innsbruck, Austria
[3] Univ Innsbruck Hosp, Dept Haematol & Oncol, A-6020 Innsbruck, Austria
[4] Ctr Outcomes Res & Educ, Evanston, IL USA
关键词
D O I
10.1080/02841860310023453
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aims of this study were to derive population-based reference values for the Functional Assessment of Cancer Therapy Scale - General (FACT-G) and to investigate the impact of sociodemographic variables (e.g. age, sex, health status) on these quality of life (QOL) scores, and to compare the normative QOL scores with those of various groups of cancer survivors. A random sample of 2 000 members of the Austrian public were sent questionnaires containing the FACT-G and questions relating to demographic data and health status. A total of 968 questionnaires were returned giving an overall response rate of 50.6% ( females 48.3%, age 49.3 +/- 16.8). Subjects with higher education reported higher QOL values; divorced and widowed persons had significantly lower QOL scores. Higher age was also associated with lower QOL scores. After bone marrow transplantation, patients generally showed lower QOL scores than the age- and sex-matched population-based sample, whilst in breast cancer survivors there was reduced QOL regarding social well-being. Survivors of Hodgkin's disease were found to have higher functional and social well-being scores than those of the general population sample. Sociodemographic variables should always be taken into consideration when interpreting QOL scores. Furthermore, unless patient data are compared with normative values, phenomena such as adaptation and response shift might be missed or misinterpreted.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 30 条
[1]   Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations [J].
Aaronson, NK ;
Muller, M ;
Cohen, PDA ;
Essink-Bot, ML ;
Fekkes, M ;
Sanderman, R ;
Sprangers, MAG ;
Velde, AT ;
Verrips, E .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1055-1068
[2]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[3]   THE SWEDISH HEALTH-RELATED QUALITY-OF-LIFE SURVEY (SWED-QUAL) [J].
BRORSSON, B ;
IFVER, J ;
HAYS, RD .
QUALITY OF LIFE RESEARCH, 1993, 2 (01) :33-45
[4]   Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population [J].
Cella, D ;
Zagari, MJ ;
Vandoros, C ;
Gagnon, DD ;
Hurtz, HJ ;
Nortier, JWR .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :366-373
[5]  
Cella D, 1997, MANUAL FUNCTIONAL AS
[6]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[7]  
Dapueto JJ, 2001, PSYCHO-ONCOL, V10, P88
[8]   MEASURING PSYCHOLOGICAL AND PHYSICAL DISTRESS IN CANCER-PATIENTS - STRUCTURE AND APPLICATION OF THE ROTTERDAM-SYMPTOM-CHECKLIST [J].
DEHAES, JCJM ;
VANKNIPPENBERG, FCE ;
NEIJT, JP .
BRITISH JOURNAL OF CANCER, 1990, 62 (06) :1034-1038
[9]   An evaluation of the quality of life among long-term survivors of breast cancer [J].
Dow, KH ;
Ferrell, BR ;
Leigh, S ;
Ly, J ;
Gulasekaram, P .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 39 (03) :261-273
[10]   Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30 [J].
Fayers, PM .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) :1331-1334